article · Physiological Reports
Stress-induced hemodynamic reactivity was categorized as predominant alpha (α)- and beta (β)-adrenergic reactivity profiles. Within these profiles, we investigated resting neuroendocrine markers, their associations with hemodynamic reactivity, and odds of an α- or β-adrenergic reactivity profile. We included 375 teachers (20-65 years) and recorded one-minute beat-to-beat hemodynamic reactivity during Stroop-Color-Word-Conflict-test. We categorized α-responders [lowest-quartile ∆%CO, ∆%Cwk; n = 49], β-responders [highest-quartile ∆%CO, ∆%Cwk; n = 69], mixed-α/β-responders [remaining n = 257]. Baseline fasting serum adrenocorticotropic hormone (ACTH), cortisol, urinary norepinephrine-to-creatinine (u-NE/Cr), and epinephrine-to-creatinine (u-EPI/Cr) ratios were measured. Predominant α-responders were older with greater hypertension prevalence than other responders. In α-responders, u-NE/Cr inversely, and ACTH and cortisol positively associated with ∆%CO and ∆%Cwk (all p ≤ 0.044). In β-responders, u-NE/Cr positively associated with ∆%CO, u-EPI/Cr inversely with ∆%CO, and positively with ∆%Cwk (all p ≤ 0.045). Odds of an α-profile were higher with u-NE/Cr, ACTH, and cortisol in the highest-quartile (all p ≤ 0.004). Odds of a β-profile were higher with u-NE/Cr in the highest-quartile and ACTH and cortisol in the lowest-quartile (all p ≤ 0.006). Predominant α-responders exhibited higher u-NE/Cr, ACTH, and cortisol, suggesting vascular risk through peripheral vasoconstriction. Predominant β-responders showed higher u-NE/Cr only, suggesting adaptive cardiac performance via catecholaminergic drive. These findings reveal distinct neuroendocrine underpinnings with implications for personalized acute stress cardiovascular phenotyping.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.14814/phy2.70809
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.